T-cell studies in insulin-dependent diabetes mellitus: Lessons from other autoimmune diseases

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 10, Issue 5, 1997, Pages 242-254

  Stevens, E J ^a   Peakman, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmune thyroid disease; IDDM; Multiple sclerosis; Proliferation studies; T cells

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; HLA ANTIGEN CLASS 2;

AUTOIMMUNE DISEASE; CELL PROLIFERATION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0031417606     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Gepts W., Lecompte P.: The pancreatic islets in diabetes. Am. J. Med. 70: 105-115, 1981.
2. Peakman M.: Role of T lymphocytes in the aetiology of insulin-dependent diabetes. Frontiers Horm. Res. 22: 90-108, 1997.
3. Roep B.: T-cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes 45: 1147-1156, 1996.
4. Eguchi K., Matsuoka N., Nagataki S.: Cellular immunity in autoimmune thyroid disease. Baillieres Clin. Endocrinol. Metab. 9: 71-94, 1995.
5. Hafler D., Weiner H.: Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75-107, 1995.
6. Westerman J., Pabst R.: Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol. Today 11:406-410, 1990.
7. Seidel D., Ziegel A.: Prediction of Type 1 diabetes. Horm. Res. 45: 36-39, 1996.
8. Simone E., Eisenbarth G.: Chronic autoimmunity of Type 1 diabetes. Horm. Metab. Res. 28: 332-336, 1996.
9. Sutherland D., Goetz F., Sibley R.: Recurrence of disease in pancreas transplants. Diabetes 38: 85-87, 1989.
10. Maran R., Dueymes M., Le-Corre R., Ranaudineau Y., Shoenfeld Y., Youinou P.: IgG subclasses of human autoantibodies. Ann. Med. Interne Paris 148: 29-38, 1997.
11. Ou D., Mitchell L., Tingle A.: HLA-DR' restrictive supertypes dominate promiscuous T-cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. J. Rheumatol. 24: 253-261, 1997.
12. Palmer J., Asplin C., Clemons P., Lyen K., Tatpati O., Raghu P., Paquette T.: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339, 1983.
13. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olessen H., DeCamilli P., DeCamilli P.: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
14. Payton M., Hawkes C., Christie M.: Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest 96: 1506-1511, 1995.
15. Hawkes C., Wassmeier C., Christie M., Hutton J.: Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 45: 1187-1192, 1996.
16. Castano L., Russo E., Zhou L., Lipes M., Eisenbarth G.: Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J. Clin. Endocrinol. Metab. 73: 1197-1201, 1991
17. Aanstoot H., Kang S., Kim J., Lindsay L., Roll U., Knip M., Atkinson M., Mose-Larsen P., Fey S., Ludvigsson J.: Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes. J. Clin. Invest. 97: 2772-2783, 1996.
18. Karounos D., Thomas J.: Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM. Diabetes 39: 1085-1090, 1990.
19. Pietropaolo M., Castano L., Babu S., Buelow R., Kuo Y., Martin S., Martin A., Powers A., Prochazka M., Naggert J., Leiter E., Eisenbarth G.: Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterisation of a novel diabetes-associated autoantigen. J. Clin. Invest. 92: 359-371, 1993.
20. Johnson D., Hafler D., Fallis R., Lees M., Brady R.: Cell- mediated immunity to myelin-associated glycoprotein, proteolipid protein and myelin basic protein in multiple sclerosis. J. Neuroimmunol. 13: 99-108, 1986.
21. Zhang J., Medaer R., Chin Y., van den Berg-Loonen E., Raus J.: Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32: 330, 1992.
22. Correale J., McMillan M., McCarthy K., Le T., Weiner L.: Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurol. 45: 1370-1378, 1995.
23. Weetman A., Gunn C., Hall R., McGregor A.: Thyroid autoantigen-induced lymphocyte proliferation in Grave's disease and Hashimoto's thyroiditis. J. Clin. Lab. Immunol. 17: 1-6, 1985.
24. Fukuma N., McLachlan S., Rapoport B., Goodacre J., Middleton S., Phillips D., Pegg C., Rees-Smith B.: Thyroid autoantigens and human T-cell responses. Clin. Exp. Immunol. 82: 275-283, 1990.
25. Ewins D., Barnett P., Ratanachaiyavong S., Sharrock C., Lanchbury J., McGregor A., Banga J.: Antigen-specific T-cell recognition of affinity-purified and recombinant thyroid peroxidase in autoimmune thyroid disease. Clin. Exp. Immunol. 90: 93-98, 1992.
26. Soliman M., Kaplan E., Fisfalen M., Okamoto Y., DeGroot L.: T-cell reactivity to recombinant thyrotropin receptor extracellular domain and thyroglobulin in patients with autoimmune and nonautoimmune thyroid disease. J. Clin. Endocrinol. Metab. 80: 206-213, 1995.
27. Soliman M., Kaplan E., Yanagawa T., Hidaka Y., Fisfalen M., DeGroot L.: T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain. J. Clin. Endocrinol. Metab. 80: 905-914, 1995.
28. Fisfalen M., Soliman M., Okamoto Y., Soltani K., DeGroot L.: Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 80: 1597-1604, 1995.
29. Scheinin T., Groop L., Nikkila E., Kontiainen S.: Proliferative responses to insulin antigens in diabetics and controls. J. Clin. Lab. Immunol. 11: 135, 1983
30. Scheinin T., Maenpaa J., Koskimies S., Dean B., Bottazzo G.: Insulin responses and lymphocyte subclasses in children with newly diagnosed insulin-dependent diabetes. Immunol. 71: 91-95, 1988.
31. Atkinson M., Kaufman D., Campbell L., Gibbs K., Shah S., Bu D., Erlander M., Tobin A., Maclaren N.: Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459, 1992.
32. Honeyman M., Cram D., Harrison L.: Glutamic acid decarboxylase 67-reactive T-cells: A marker of insulin-dependent diabetes. J. Exp. Med. 177: 535-540, 1993.
33. Harrison L., Honeyman M., DeAizpurua H., Schmidli R., Colman P., Tait B., Cram D.: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369, 1993.
34. Cavallo M., Fava D., Monetini L., Barone F., Pozzilli P.: Cell-mediated immune response to β casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet 348: 926-928, 1996.
35. Durinovic-Bello I., Hummel M., Ziegler A.: Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 45: 795-800, 1996.
36. Shimojo N., Saito K., Kohno Y., Sasaki N., Tarutani O., Nakajima H.: Antigenic determinants on thyroglobulin: comparison of the reactivities of different thyroglobulin preparations with serum antibodies and T-cells of patients with chronic thyroiditis. J. Clin. Endocrinol. Metab. 66: 689-695, 1988.
37. Tandon N., Freeman M., Weetman A.: T-cell responses to synthetic TSH receptor peptides in Graves' disease. Clin. Exp. Immunol. 89: 468-473, 1992.
38. Tandon N., Freeman M., Weetman A.: T-cell responses to synthetic thyroid peroxidase peptides in autoimmune thyroid disease. Clin. Exp. Immunol. 86: 56-60, 1991.
39. Kawakami Y., Fisfalen M., DeGroot L.: Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid disease to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 13: 17-26, 1992.
40. Atkinson M., Bowman M., Campbell L., Darrow B., Kaufman D., Maclaren N.: Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94: 2125-2129, 1994.
41. Lohmann T., Leslie R., Hawa M., Geysen M., Rodda S., Londei M.: Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343: 1607-1608, 1994.
42. Lehmann P., Sercarz E., Forsthuber T., Dayan C., Gammon G.: Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14: 203-208, 1993.
43. Nagy E., Morris J., Burch H., Bhatia S., Salata K., Burman K.: Thyrotropin receptor T-cell epitopes in autoimmune thyroid disease. Clin. Immunol. Immunopathol. 75: 117-124, 1995
44. Tuohy V., Yu M., Weinsiock-Guttman B., Kinkel R.: Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99: 1682-1690, 1997.
45. Feldmann M., Dayan C., Rapoport B., Londei M.: T-cell activation and antigen presentation in human thyroid autoimmunity. J. Autoimmunity 5 Suppl. A: 115-121, 1992.
46. Hawkes C., Stevens E., Christie M.: T-cell responses to the tyrosine phosphatase-like molecule IA-2 in IDDM. Diabetic Med. 14: S22, 1997.
47. van Noort J., van Sechel A., Bajramovic J., Ouagamiri M., Polman C., Lassmann H., Ravid R.: The small heatshock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 375: 798-801, 1995.
48. Roep B., Kallan A., Duinkerken G., Arden S., Hutton J., Bruining H., de Vries R.: T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 44: 278-283, 1995.
49. Canonica G., Cosulich M., Croci R., Ferrini S., Bagnasco M., Dirienzo W., Ferrini O., Bargellesi A., Giordano G.: Thyroglobulin-induced T-cell in vitro proliferation in Hashimoto's thyroiditis: identification of the responsive subset and effect of monoclonal antibodies directed to Ia antigens. Clin. Immunol. Immunopathol. 32: 132-141, 1984.
50. Canonica G., Caria M., Bagnasco M., Cosulich M., Giordano G., Moretta L.: Proliferation of T8-positive cytolytic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis: analysis of cell interactions and culture requirements. Clin. Immunol. Immunopathol. 36: 40-48, 1985.
51. Smerdon R., Peakman M., Hussain M., Alviggi L., Watkins P., Leslie R., Vergani D.: Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes 42: 127-133, 1993.
52. Buschard K., Ropke C., Madsbad S., Mehlsen J., Rygaard J.: T lymphocyte subsets in patients with newly-diagnosed type 1 (insulin-dependent) diabetes: a prospective study. Diabetologia 25: 247-251, 1983.
53. Tun R., Peakman P., Alviggi L., Hussain M., Lo S., Shattock M., Pyke D., Bottazzo G., Vergani D., Leslie R.: The importance of persistent cellular and humoral immune changes in the prediabetic period: a prospective study. Br. Med. J. 308: 1063-1068, 1994.
54. DeFreitas E., Sanberg-Wollheim M., Schonely K., Boufal M., Koprowski H.: Regulation of interleukin 2 receptors on T-cells from multiple sclerosis patients. Proc. Natl. Acad. Sci. USA 83: 2637-1641, 1986.
55. +. Clin. Exp. Immunol. 73: 255-259, 1988.
56. +, CD28-suppressor cell. Ann. Neurol. 30: 42-47, 1991.
57. Bongioanni P., Meucci G.: T-cell tumor necrosis factor- alpha receptor binding in patients with multiple sclerosis. Neurol. 48: 826-831, 1997.
58. 7-integrin. Diabetes 46: 583-588, 1997.
59. Janeway C., Bottomly K.: Signals and signs for lymphocyte responses. Cell 76: 275-285, 1994.
60. Squire C., Studer E., Lees A., Finkelman F., Conrad D.: Antigen presentation is enhanced by targeting antigen to the FceRII antigen-anti-FceRII conjugates. J. Immunol. 152: 4388-4396, 1994.
61. + T-cells induced by dendritic cells following antigen uptake in the presence of specific antibody. Vet. Immunol. Immunopathol. 49: 321-330, 1996.
62. Guo J., Quaratino S., Jaume J., Costante G., Londei M., McLachlan S., Rapoport B.: Autoantibody-mediated capture and presentation of autoantigen to T-cells via the Fcε receptor by a recombinant human autoantibody Fab converted to IgE. J. Immunol. Meth. 195: 81-92, 1996.
63. Stevens E., Hawkes C., Christie M., Peakman M.: Enhanced detection of T-cell proliferation to IA-2 by targeting antigen presenting cells. Diabetologia 40: A86, 1997.
64. Sharrock C., Kaminski E., Man S.: Limiting dilution analysis of human T-cells: A useful clinical tool. Immunol. Today 11:281 -285, 1990.
65. Jingwu Z., Medaer R., Hashim G., Chin Y., van den BergLoonen E., Raus J.: Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursors frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32: 330-338, 1992.
66. Zhang J., Markovic Plese S., Lacet B., Raus J., Weiner H., Hafler D.: Increased frequency of interleukin 2-responsive T-cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179: 973-984, 1994.
67. Martin R., Voskuhl R., Flerlage M., McFarlin D., McFarland H.: Myelin basic protein-specific T-cell responses in identical twins discordant of concordant for multiple sclerosis. Ann. Neurol. 34: 524-535, 1993.
68. Bieganowska K., Ausubel L., Modabber Y., Slovik E., Messersmith W., Hafler D.: Direct ex vivo analysis of activated, Fas-sensitive autoreactive T-cells in human autoimmune disease. J. Exp. Med. 185: 1585-1594, 1997.
69. Naserke H., Durinovic-Bello I., Seidel D., Ziegler A.: The T-cell receptor beta chain CDR3 region of BV8S1/BJ1S5 transcripts in type 1 diabetes. Immunogenetics 45: 87-96, 1996.
70. Ota K., Matsui M., Milford E., Mackin G., Weiner H., Hafler D.: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346: 183-187, 1990.
71. + T-cells from multiple sclerosis patients. J. Neuroimmunol. 46: 33-42, 1993.
72. Pender M., Csurhes P., Houghten R., McCombe P., Good M.: A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein. J. Neuroimmunol. 70: 65-74, 1996.
73. Fisfalen M., DeGroot L., Quintans J., Franklin W., Soltani K.: Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Grave's disease. J. Clin. Endocrinol. Metab. 66: 776-784, 1988.
74. Pette M., Fujita K., Kitze B., Whitaker J., Albert E., Kappos L., Wekerle H.: Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurol. 40: 1770-1776, 1990.
75. Chou Y., Henderix P., Vainiene M., Whitham R., Bourdette D., Chou C., Hashim G., Offner H., Vandenbark A.: Specificity of human T-cell clones reactive to immunodominant epitopes of myelin basic protein. J. Neurosci. Res. 28: 280-290, 1991.
76. Chou Y., Jones R., Bourdette D., Whitham R., Hashim G., Atherton J., Offner H., Vandenbark A.: Human myelin basic protein (MBP) epitopes recognized by mouse MBP- selected T-cell lines from multiple sclerosis patients. J. Neuroimmunol. 49: 45-50, 1994.
77. Liblau R., Tournier-Lasserve E., Maciazek J., Dumas G., Siffert O., Hashim G., Bach M.: T-cell response to myelin sclerosis patients and healthy subjects. Eur. J. Immunol. 21: 1391-1395, 1991.
78. Chou Y., Vainiene M., Whitham R., Bourdette D., Chou C., Hashim G., Offner H., Vandenbark A.: Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J. Neurosci. Res. 23: 207-216, 1989.
79. Shanmugam A., Copie-Bergman C., Caillat S., Bach J., Toumier-Lasserve E.: In vivo clonal expression of T lymphocytes specific for an immunodominant N-terminal myelin basic protein epitope in healthy individuals. J. Neuroimmunol. 59: 165-172, 1995.
80. Lohmann T., Leslie R., Londei M.: T-cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmunity 9: 385-389, 1996.
81. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmitz G., Meini E., Hummel M., Ziegler A., Wank R., Schendel D.: Identification of naturally processed T-cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99: 2405-2415, 1997.
82. + T-cells from multiple sclerosis patients. J. Neuroimmunol. 53: 153-161, 1994.
83. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., Kuchroo V., Hafler D.: T-cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155: 982-992, 1995.
84. Lanzavecchia A.: How can 'cryptic' epitopes trigger autoimmunity?[Comment]. J. Exp. Med. 181: 1945-1948, 1995.
85. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91: 10859-10863, 1994.
86. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J. Neuroimmunol. 73: 7-14, 1997.
87. Panina Bordignon P., Lang R., van Endert P., Benazzi E., Felix A., Pastore R., Spinas G., Sinigaglia F.: Cytotoxic T-cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181: 1923-1927, 1995.
88. Londei M., Bottazzo G., Feldmann M.: Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 228: 85, 1985.
89. Peakman M., Wen L., McNab G., Watkins P., Tan K., Vergani D.: T-cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity 17: 31-39, 1994.
90. Allegretta M., Nicklas J., Sriram S., Albertini R.: T-cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247: 718-721, 1990.
91. Huang G., Tremble J., Bailyes E., Arden S., Kaye T., McGregor A., Banga J.: HLA-DR-restricted T-cell lines from newly diagnosed type 1 diabetic patients specific for insulinoma and normal islet beta cell proteins: Lack of reactivity to glutamic acid decarboxylase. Clin. Exp. Immunol. 102: 152-158, 1995.
92. Roep B., Arden S., de Vries R., Hutton J.: T-cell clones from a type-1 diabetes patients respond to insulin secretory granule proteins. Nature 345: 632-634, 1990.
93. McLaurin J., Hafler D., Antel J.: Reactivity of normal T- cell lines to MBP isolated from normal and multiple sclerosis white matter. J. Neurol. Sci. 128: 205-211, 1995.
94. MacKenzie W., Schwartz A., Friedman E., Davies T.: Intrathyroidal T-cell clones from patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 64: 818-824, 1987.
95. Dayan C., Londei M., Corcoran A., Grubeck-Loebenstein B., James R., Rapoport B., Feldmann M.: Autoantigen recognition by thyroid-infiltrating T-cells in Graves' disease. Proc. Natl. Acad. Sci. USA 88: 7415-7419, 1991.
96. Hidaka Y., Hayashi Y., Fisfalen M., Suzuki S., Takeda T., Refetoff S., DeGroot L.: Expression of thyroid peroxidase in EBV-transformed β-cell lines using adenovirus. Thyroid 6: 23-28, 1996.
97. Mullins R., Cohen S., Webb L., Chernajovsky Y., Dayan C., Londei M., Feldmann M.: Identification of thyroid stimulating hormone receptor-specific T-cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus- transformed β-cell lines. J. Clin. Invest. 96: 30-37, 1995.
98. Merrill J., Kagan J., Schmid I., Strom S., Quan S., Chen I.: T-cell lines established from multiple sclerosis cerebrospinal fluid T-cells using human retroviruses. J. Neuroimmunol. 21: 213-226, 1989.
99. Weber F., Meinl E., Drexler K., Czlonkowska A., Huber S., Fickenscher H., Muller-Fleckenstein I., Fleckenstein B., Wakerle H., Hohlfeld R.: Transformation of human T-cell clones by Herpesvirus saimiri: intact antigen recognition by autonomously growing myelin basic protein- specific T-cells. Proc. Natl. Acad. Sci. USA 90: 11049-11053, 1993.
100. Wucherpfennig K., Sette A., Southwood S., Oseroff C., Matsui M., Strominger J., Hafler D.: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T-cell clones. J. Exp. Med. 179: 279-290, 1994.
101. Hemmer B., Fleckenstein B., Vergelli M., Jung G., McFarland H., Martin R., Wiesmuller K.: Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T-cell clone. J. Exp. Med. 185: 1651-1659, 1997.
102. Hollsberg P., Batra V., Dressel A., Hafler D.: Induction of anergy in CD8 cells by β-cell presentation. J. Immunol. 157: 5269-5276, 1996.
103. Bagnasco M., Venuti D., Prigione I., Torre G., Ferrini S., Canonica G.: Graves' disease: phenotypic and functional analysis at the clonal level of the T-cell repertoire in peripheral blood and in thyroid. Clin. Immunol. Immunopathol. 47: 230-239, 1988.
104. + T-cells independent for tumor necrosis factor. Ann. Neurol. 35: 341-348, 1994.
105. Bottazzo G., Dean B., McNally J., MacKay E., Swift P., Gamble R.: In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 313: 353-360, 1985.
106. Martin D., Sheng-Tanner X., Miller R.: Rapid and long- term changes to host cytotoxic T lymphocyte precursors reactive to donor antigens caused by intravenous injection of histoincompatible lymphocytes. Transplant. 54: 125-129, 1992.
107. Voskhul R., Martin R., Bergman C., Dalal M., Ruddle N., McFarland H.: T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15: 137-143, 1993.
108. Vergelli M., Hemmer B., Utz U., Vogt A., Kalbus M., Tranquill L., Conlon P., Ling N., Steinman L., McFarland H., Martin R.: Differential activation of human autoreactive T-cell clones by altered peptide ligands derived from myelin basic protein peptide. Eur. J. Immunol. 26: 2624-2634, 1996.
109. Martin A., Valentine M., Unger P., Lichtenstein C., Schwartz A., Friedman E., Shultz L., Davies T.: Preservation of functioning human thyroid organoids in the scid mouse: 1. System characterisation. J. Clin. Endocrinol. Metab. 77: 305-310, 1993.
110. Dore-Duffy P , Donaldson J., Thompson H., Leuze M.: Lymphocyte adherence to myelinated tissue in multiple sclerosis: correlation with disease activity. Neurol. 36: 1500-1503, 1986.
111. Fukazawa H., Hiromatsu Y., Bernard N., Salvi M., Wall J.: Binding of peripheral blood and thyroidal T lymphocytes to thyroid cell monolayers: possible role of "homing-like" receptors in the pathogenesis of thyroid autoimmunity. Autoimmunity 10: 181-188, 1991.
112. LaSalle J., Ota K., Hafler D.: Presentation of autoantigen by human T-cells. J. Immunol. 147: 774-780, 1991.
113. + T-cells via CD40 ligand. Proc. Nat. Acad. Sci. USA 94: 599-603, 1997.
114. Koprowski H., DeFreitas E., Harper M., Sandberg-Wollheim M., Sheremata W., Robert-Guroff M., Saxinger C., Feinberg M., Wong-Staal F., Gallo R.: Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature 318: 154-160, 1985.
115. Burns J., Littlefield K., Gill J., Trotter L: Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens. Ann. Neurol. 32: 352-357, 1992.
116. Zhang J., Vandevyver C., Stinissen P., Mertens N., van den Berg-Loonen E., Raus J.: Activation and clonal expansion of human myelin basic protein-reactive T-cells by bacterial superantigens. J. Autoimmunity 8: 615-632, 1995.
117. Baum H., Davies H., Peakman M.: Molecular mimicry in the MHC:hidden clues to autoimmunity? Immunol. Today 17: 64-70, 1996.
118. Graves P., Norris J., Pallansch M., Gerling I., Rewers M.: The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 46: 161-168, 1997.
119. Windhagen A., Scholz C., Hollsberg P., Fukaura H., Sette A., Hafler D.: Modulation of cytokine patterns of human autoreactive T-cell clones by a single amino acid substitution of their peptide ligand. Immunity 2: 373-380, 1995.
120. Rep M., Hintzen R., Polman C., van Lier R.: Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 65: 111-118, 1996.
121. Dayan C., Chu N., Londei M., Rapoport B., Feldmann M.: T-cells involved in human autoimmune disease are resistant to tolerance induction. J. Immunol. 151: 1606-1613, 1993.
122. Rep M., van Oosten B., Roos M., Ader H., Polman C., van Lier R.: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T-cells but does not affect IFN-gamma secreting TH1 cells in humans. J. Clin. Invest. 99: 2225-2231, 1997.
123. Zhang J., Stinissen P., Medaer R., Raus J.: T-cell vaccination: clinical application in autoimmune diseases. J. Mol. Med. 74: 653-662, 1996.
124. Weiner H.: Oral tolerance for the treatment of autoimmune disease. Ann. Rev. Med. 48: 341-351, 1997.